Cite
HARVARD Citation
Hochmair, M. et al. (n.d.). Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study. Lung cancer. pp. S59-S60. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hochmair, M. et al. (n.d.). Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study. Lung cancer. pp. S59-S60. [Online].